BiTE-based immunotherapy strategy could point the way to a breakthrough for ovarian cancer patients

Results of a study led by researchers at Roswell Park Comprehensive Cancer Center show that combining two types of immunotherapy—engineered T cells that secrete bispecific T cell engagers (BiTEs) and ...